Global Nutrigenomics Market
Global Nutrigenomics Market

Nutrigenomics Comprehensive Study by Type (Reagents & kits, Services), Application (Obesity, Diabetes, Anti-Aging, Chronic Diseases) Players and Region - Global Market Outlook to 2024

Nutrigenomics Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024  

May 2019 Edition 220 Pages 196 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Scope of the Study
Nutrigenomics is defined as basically interaction of nutrition and genes in order to the treatment of disease. It is also known as nutritional genomics. Numerous benefits of using nutrigenomics testing such as allows them to make positive changes to their lifestyle, shifting the focus from disease management to disease prevention and health promotion and other benefits. Introduction and development of direct to consumer nutrigenomics kits and rising intake of specialized food and diet are some of the major drivers which are propelling the growth of the market. The market for the nutrigenomics is expected to register a CAGR of over 5.2% during the forecast period.

The market study is being classified by Type (Reagents & kits and Services), by Application (Obesity, Diabetes, Anti-Aging and Chronic Diseases) and major geographies with country level break-up.

Cura Integrative Medicine (Australia), NutraGene (United States), XCODE Life Science Pvt. Ltd. (India), Nutrigenomix (Canada), WellGen Inc. (United States), Genomix Nutrition Inc. (United States), Royal DSM (Netherlands), BASF SE (Germany), Danone S.A (France) and GeneSmart (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Unilever (United Kingdom), Genova Diagnostics (United States), NutriGenomix, Inc. (Canada), Metagenics, Inc. (United States) and WellGen, Inc. (United States).

The market is fragmented with numerous players focusing on technique and quality of the product due to which the global nutrigenomics market can witness an upsurge in the forecast period. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Nutrigenomics market throughout the predicted period.

Segment Analysis
AdvanceMarketAnalytics has segmented the market of Global Nutrigenomics market by Type, Application and Region.

On the basis of geography, the market of Nutrigenomics has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Drivers
  • Rising Healthcare Expenditure, and Encouraging Government Support for Research and Development
  • Increasing Awareness of Health and Treatments
  • Increased Spending On Healthcare and a Demand for Holistic Treatments

Market Trend
  • Technology Advancement in Nutrigenomics

Restraints
  • Issue related to High Cost Associated with the Treatment

Opportunities
  • Increasing Demand from Emerging Economies such as China and India

Challenges
  • Lack of Physicians Qualified to Provide Nutrigenomics Treatments


Market Leaders and their expansionary development strategies
In April 2018, the Prenetics Limited (Hong Kong) Company has acquired DNAFit Ltd (United Kingdom) Company for more than USD 10 Million, which serves customers with pharmacogenomics, nutrigenomics, cancer, and reproductive health tests. Hence, this acquisition will help in strengthening the position of the company.



Key Target Audience
Nutrigenomics Testing Companies, Research and Development (R&D) Companies, Research Organization, Federal Agencies and Others

Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Reagents & kits
  • Services
By Application
  • Obesity
  • Diabetes
  • Anti-Aging
  • Chronic Diseases
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Healthcare Expenditure, and Encouraging Government Support for Research and Development
      • 3.2.2. Increasing Awareness of Health and Treatments
      • 3.2.3. Increased Spending On Healthcare and a Demand for Holistic Treatments
    • 3.3. Market Challenges
      • 3.3.1. Lack of Physicians Qualified to Provide Nutrigenomics Treatments
    • 3.4. Market Trends
      • 3.4.1. Technology Advancement in Nutrigenomics
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Nutrigenomics, by Type, Application and Region (value) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Nutrigenomics (Value)
      • 5.2.1. Global Nutrigenomics by: Type (Value)
        • 5.2.1.1. Reagents & kits
        • 5.2.1.2. Services
      • 5.2.2. Global Nutrigenomics by: Application (Value)
        • 5.2.2.1. Obesity
        • 5.2.2.2. Diabetes
        • 5.2.2.3. Anti-Aging
        • 5.2.2.4. Chronic Diseases
      • 5.2.3. Global Nutrigenomics Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Nutrigenomics: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Cura Integrative Medicine (Australia)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. NutraGene (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. XCODE Life Science Pvt. Ltd. (India)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Nutrigenomix (Canada)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. WellGen Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Genomix Nutrition Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Royal DSM (Netherlands)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. BASF SE (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Danone S.A (France)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. GeneSmart (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Nutrigenomics Sale, by Type, Application and Region (value) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Nutrigenomics (Value)
      • 7.2.1. Global Nutrigenomics by: Type (Value)
        • 7.2.1.1. Reagents & kits
        • 7.2.1.2. Services
      • 7.2.2. Global Nutrigenomics by: Application (Value)
        • 7.2.2.1. Obesity
        • 7.2.2.2. Diabetes
        • 7.2.2.3. Anti-Aging
        • 7.2.2.4. Chronic Diseases
      • 7.2.3. Global Nutrigenomics Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Nutrigenomics: by Type(USD Million)
  • Table 2. Nutrigenomics Reagents & kits , by Region USD Million (2013-2018)
  • Table 3. Nutrigenomics Services , by Region USD Million (2013-2018)
  • Table 4. Nutrigenomics: by Application(USD Million)
  • Table 5. Nutrigenomics Obesity , by Region USD Million (2013-2018)
  • Table 6. Nutrigenomics Diabetes , by Region USD Million (2013-2018)
  • Table 7. Nutrigenomics Anti-Aging , by Region USD Million (2013-2018)
  • Table 8. Nutrigenomics Chronic Diseases , by Region USD Million (2013-2018)
  • Table 9. South America Nutrigenomics, by Country USD Million (2013-2018)
  • Table 10. South America Nutrigenomics, by Type USD Million (2013-2018)
  • Table 11. South America Nutrigenomics, by Application USD Million (2013-2018)
  • Table 12. Brazil Nutrigenomics, by Type USD Million (2013-2018)
  • Table 13. Brazil Nutrigenomics, by Application USD Million (2013-2018)
  • Table 14. Argentina Nutrigenomics, by Type USD Million (2013-2018)
  • Table 15. Argentina Nutrigenomics, by Application USD Million (2013-2018)
  • Table 16. Rest of South America Nutrigenomics, by Type USD Million (2013-2018)
  • Table 17. Rest of South America Nutrigenomics, by Application USD Million (2013-2018)
  • Table 18. Asia Pacific Nutrigenomics, by Country USD Million (2013-2018)
  • Table 19. Asia Pacific Nutrigenomics, by Type USD Million (2013-2018)
  • Table 20. Asia Pacific Nutrigenomics, by Application USD Million (2013-2018)
  • Table 21. China Nutrigenomics, by Type USD Million (2013-2018)
  • Table 22. China Nutrigenomics, by Application USD Million (2013-2018)
  • Table 23. Japan Nutrigenomics, by Type USD Million (2013-2018)
  • Table 24. Japan Nutrigenomics, by Application USD Million (2013-2018)
  • Table 25. India Nutrigenomics, by Type USD Million (2013-2018)
  • Table 26. India Nutrigenomics, by Application USD Million (2013-2018)
  • Table 27. South Korea Nutrigenomics, by Type USD Million (2013-2018)
  • Table 28. South Korea Nutrigenomics, by Application USD Million (2013-2018)
  • Table 29. Taiwan Nutrigenomics, by Type USD Million (2013-2018)
  • Table 30. Taiwan Nutrigenomics, by Application USD Million (2013-2018)
  • Table 31. Australia Nutrigenomics, by Type USD Million (2013-2018)
  • Table 32. Australia Nutrigenomics, by Application USD Million (2013-2018)
  • Table 33. Rest of Asia-Pacific Nutrigenomics, by Type USD Million (2013-2018)
  • Table 34. Rest of Asia-Pacific Nutrigenomics, by Application USD Million (2013-2018)
  • Table 35. Europe Nutrigenomics, by Country USD Million (2013-2018)
  • Table 36. Europe Nutrigenomics, by Type USD Million (2013-2018)
  • Table 37. Europe Nutrigenomics, by Application USD Million (2013-2018)
  • Table 38. Germany Nutrigenomics, by Type USD Million (2013-2018)
  • Table 39. Germany Nutrigenomics, by Application USD Million (2013-2018)
  • Table 40. France Nutrigenomics, by Type USD Million (2013-2018)
  • Table 41. France Nutrigenomics, by Application USD Million (2013-2018)
  • Table 42. Italy Nutrigenomics, by Type USD Million (2013-2018)
  • Table 43. Italy Nutrigenomics, by Application USD Million (2013-2018)
  • Table 44. United Kingdom Nutrigenomics, by Type USD Million (2013-2018)
  • Table 45. United Kingdom Nutrigenomics, by Application USD Million (2013-2018)
  • Table 46. Netherlands Nutrigenomics, by Type USD Million (2013-2018)
  • Table 47. Netherlands Nutrigenomics, by Application USD Million (2013-2018)
  • Table 48. Rest of Europe Nutrigenomics, by Type USD Million (2013-2018)
  • Table 49. Rest of Europe Nutrigenomics, by Application USD Million (2013-2018)
  • Table 50. MEA Nutrigenomics, by Country USD Million (2013-2018)
  • Table 51. MEA Nutrigenomics, by Type USD Million (2013-2018)
  • Table 52. MEA Nutrigenomics, by Application USD Million (2013-2018)
  • Table 53. Middle East Nutrigenomics, by Type USD Million (2013-2018)
  • Table 54. Middle East Nutrigenomics, by Application USD Million (2013-2018)
  • Table 55. Africa Nutrigenomics, by Type USD Million (2013-2018)
  • Table 56. Africa Nutrigenomics, by Application USD Million (2013-2018)
  • Table 57. North America Nutrigenomics, by Country USD Million (2013-2018)
  • Table 58. North America Nutrigenomics, by Type USD Million (2013-2018)
  • Table 59. North America Nutrigenomics, by Application USD Million (2013-2018)
  • Table 60. United States Nutrigenomics, by Type USD Million (2013-2018)
  • Table 61. United States Nutrigenomics, by Application USD Million (2013-2018)
  • Table 62. Canada Nutrigenomics, by Type USD Million (2013-2018)
  • Table 63. Canada Nutrigenomics, by Application USD Million (2013-2018)
  • Table 64. Mexico Nutrigenomics, by Type USD Million (2013-2018)
  • Table 65. Mexico Nutrigenomics, by Application USD Million (2013-2018)
  • Table 66. Company Basic Information, Sales Area and Its Competitors
  • Table 67. Company Basic Information, Sales Area and Its Competitors
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Nutrigenomics: by Type(USD Million)
  • Table 77. Nutrigenomics Reagents & kits , by Region USD Million (2019-2024)
  • Table 78. Nutrigenomics Services , by Region USD Million (2019-2024)
  • Table 79. Nutrigenomics: by Application(USD Million)
  • Table 80. Nutrigenomics Obesity , by Region USD Million (2019-2024)
  • Table 81. Nutrigenomics Diabetes , by Region USD Million (2019-2024)
  • Table 82. Nutrigenomics Anti-Aging , by Region USD Million (2019-2024)
  • Table 83. Nutrigenomics Chronic Diseases , by Region USD Million (2019-2024)
  • Table 84. South America Nutrigenomics, by Country USD Million (2019-2024)
  • Table 85. South America Nutrigenomics, by Type USD Million (2019-2024)
  • Table 86. South America Nutrigenomics, by Application USD Million (2019-2024)
  • Table 87. Brazil Nutrigenomics, by Type USD Million (2019-2024)
  • Table 88. Brazil Nutrigenomics, by Application USD Million (2019-2024)
  • Table 89. Argentina Nutrigenomics, by Type USD Million (2019-2024)
  • Table 90. Argentina Nutrigenomics, by Application USD Million (2019-2024)
  • Table 91. Rest of South America Nutrigenomics, by Type USD Million (2019-2024)
  • Table 92. Rest of South America Nutrigenomics, by Application USD Million (2019-2024)
  • Table 93. Asia Pacific Nutrigenomics, by Country USD Million (2019-2024)
  • Table 94. Asia Pacific Nutrigenomics, by Type USD Million (2019-2024)
  • Table 95. Asia Pacific Nutrigenomics, by Application USD Million (2019-2024)
  • Table 96. China Nutrigenomics, by Type USD Million (2019-2024)
  • Table 97. China Nutrigenomics, by Application USD Million (2019-2024)
  • Table 98. Japan Nutrigenomics, by Type USD Million (2019-2024)
  • Table 99. Japan Nutrigenomics, by Application USD Million (2019-2024)
  • Table 100. India Nutrigenomics, by Type USD Million (2019-2024)
  • Table 101. India Nutrigenomics, by Application USD Million (2019-2024)
  • Table 102. South Korea Nutrigenomics, by Type USD Million (2019-2024)
  • Table 103. South Korea Nutrigenomics, by Application USD Million (2019-2024)
  • Table 104. Taiwan Nutrigenomics, by Type USD Million (2019-2024)
  • Table 105. Taiwan Nutrigenomics, by Application USD Million (2019-2024)
  • Table 106. Australia Nutrigenomics, by Type USD Million (2019-2024)
  • Table 107. Australia Nutrigenomics, by Application USD Million (2019-2024)
  • Table 108. Rest of Asia-Pacific Nutrigenomics, by Type USD Million (2019-2024)
  • Table 109. Rest of Asia-Pacific Nutrigenomics, by Application USD Million (2019-2024)
  • Table 110. Europe Nutrigenomics, by Country USD Million (2019-2024)
  • Table 111. Europe Nutrigenomics, by Type USD Million (2019-2024)
  • Table 112. Europe Nutrigenomics, by Application USD Million (2019-2024)
  • Table 113. Germany Nutrigenomics, by Type USD Million (2019-2024)
  • Table 114. Germany Nutrigenomics, by Application USD Million (2019-2024)
  • Table 115. France Nutrigenomics, by Type USD Million (2019-2024)
  • Table 116. France Nutrigenomics, by Application USD Million (2019-2024)
  • Table 117. Italy Nutrigenomics, by Type USD Million (2019-2024)
  • Table 118. Italy Nutrigenomics, by Application USD Million (2019-2024)
  • Table 119. United Kingdom Nutrigenomics, by Type USD Million (2019-2024)
  • Table 120. United Kingdom Nutrigenomics, by Application USD Million (2019-2024)
  • Table 121. Netherlands Nutrigenomics, by Type USD Million (2019-2024)
  • Table 122. Netherlands Nutrigenomics, by Application USD Million (2019-2024)
  • Table 123. Rest of Europe Nutrigenomics, by Type USD Million (2019-2024)
  • Table 124. Rest of Europe Nutrigenomics, by Application USD Million (2019-2024)
  • Table 125. MEA Nutrigenomics, by Country USD Million (2019-2024)
  • Table 126. MEA Nutrigenomics, by Type USD Million (2019-2024)
  • Table 127. MEA Nutrigenomics, by Application USD Million (2019-2024)
  • Table 128. Middle East Nutrigenomics, by Type USD Million (2019-2024)
  • Table 129. Middle East Nutrigenomics, by Application USD Million (2019-2024)
  • Table 130. Africa Nutrigenomics, by Type USD Million (2019-2024)
  • Table 131. Africa Nutrigenomics, by Application USD Million (2019-2024)
  • Table 132. North America Nutrigenomics, by Country USD Million (2019-2024)
  • Table 133. North America Nutrigenomics, by Type USD Million (2019-2024)
  • Table 134. North America Nutrigenomics, by Application USD Million (2019-2024)
  • Table 135. United States Nutrigenomics, by Type USD Million (2019-2024)
  • Table 136. United States Nutrigenomics, by Application USD Million (2019-2024)
  • Table 137. Canada Nutrigenomics, by Type USD Million (2019-2024)
  • Table 138. Canada Nutrigenomics, by Application USD Million (2019-2024)
  • Table 139. Mexico Nutrigenomics, by Type USD Million (2019-2024)
  • Table 140. Mexico Nutrigenomics, by Application USD Million (2019-2024)
  • Table 141. Research Programs/Design for This Report
  • Table 142. Key Data Information from Secondary Sources
  • Table 143. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Nutrigenomics: by Type USD Million (2013-2018)
  • Figure 5. Global Nutrigenomics: by Application USD Million (2013-2018)
  • Figure 6. South America Nutrigenomics Share (%), by Country
  • Figure 7. Asia Pacific Nutrigenomics Share (%), by Country
  • Figure 8. Europe Nutrigenomics Share (%), by Country
  • Figure 9. MEA Nutrigenomics Share (%), by Country
  • Figure 10. North America Nutrigenomics Share (%), by Country
  • Figure 11. Global Nutrigenomics share by Players 2018 (%)
  • Figure 12. Global Nutrigenomics share by Players (Top 3) 2018(%)
  • Figure 13. Global Nutrigenomics share by Players (Top 5) 2018(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Cura Integrative Medicine (Australia) Revenue, Net Income and Gross profit
  • Figure 16. Cura Integrative Medicine (Australia) Revenue: by Geography 2018
  • Figure 17. NutraGene (United States) Revenue, Net Income and Gross profit
  • Figure 18. NutraGene (United States) Revenue: by Geography 2018
  • Figure 19. XCODE Life Science Pvt. Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 20. XCODE Life Science Pvt. Ltd. (India) Revenue: by Geography 2018
  • Figure 21. Nutrigenomix (Canada) Revenue, Net Income and Gross profit
  • Figure 22. Nutrigenomix (Canada) Revenue: by Geography 2018
  • Figure 23. WellGen Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 24. WellGen Inc. (United States) Revenue: by Geography 2018
  • Figure 25. Genomix Nutrition Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Genomix Nutrition Inc. (United States) Revenue: by Geography 2018
  • Figure 27. Royal DSM (Netherlands) Revenue, Net Income and Gross profit
  • Figure 28. Royal DSM (Netherlands) Revenue: by Geography 2018
  • Figure 29. BASF SE (Germany) Revenue, Net Income and Gross profit
  • Figure 30. BASF SE (Germany) Revenue: by Geography 2018
  • Figure 31. Danone S.A (France) Revenue, Net Income and Gross profit
  • Figure 32. Danone S.A (France) Revenue: by Geography 2018
  • Figure 33. GeneSmart (United States) Revenue, Net Income and Gross profit
  • Figure 34. GeneSmart (United States) Revenue: by Geography 2018
  • Figure 35. Global Nutrigenomics: by Type USD Million (2019-2024)
  • Figure 36. Global Nutrigenomics: by Application USD Million (2019-2024)
  • Figure 37. South America Nutrigenomics Share (%), by Country
  • Figure 38. Asia Pacific Nutrigenomics Share (%), by Country
  • Figure 39. Europe Nutrigenomics Share (%), by Country
  • Figure 40. MEA Nutrigenomics Share (%), by Country
  • Figure 41. North America Nutrigenomics Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Cura Integrative Medicine (Australia)
  • NutraGene (United States)
  • XCODE Life Science Pvt. Ltd. (India)
  • Nutrigenomix (Canada)
  • WellGen Inc. (United States)
  • Genomix Nutrition Inc. (United States)
  • Royal DSM (Netherlands)
  • BASF SE (Germany)
  • Danone S.A (France)
  • GeneSmart (United States)
Additional players considered in the study are as follows:
Unilever (United Kingdom) , Genova Diagnostics (United States) , NutriGenomix, Inc. (Canada) , Metagenics, Inc. (United States) , WellGen, Inc. (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation